Nanalysis Scientific (1N1) Financial Statements

1 Followers

Nanalysis Scientific Financial Overview

Nanalysis Scientific's market cap is currently €11.72M. The company's EPS TTM is €-0.0031143042999999997; its P/E ratio is -3.89; Nanalysis Scientific is scheduled to report earnings on August 24, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue
Gross Profit	$ 3.97M	$ 11.14M	$ 10.24M	$ 5.17M	$ 6.06M
Operating Income	$ -12.95M	$ -9.91M	$ -1.19M	$ -3.63M	$ 58.00K
EBITDA	$ -11.85M	$ -5.67M	$ 1.38M	$ -1.86M	$ -554.00K
Net Income	$ -16.78M	$ -9.91M	$ -1.77M	$ -3.68M	$ -1.66M
Balance Sheet
Cash & Short-Term Investments	$ ―	$ ―	$ ―	$ ―	$ ―
Total Assets	$ 53.82M	$ 69.90M	$ 37.79M	$ 23.99M	$ 18.31M
Total Debt	$ 21.97M	$ 10.75M	$ 5.99M	$ 3.78M	$ 1.51M
Net Debt	$ 21.21M	$ 7.23M	$ -4.42M	$ 618.00K	$ -5.11M
Total Liabilities	$ 30.34M	$ 22.33M	$ 13.83M	$ 9.64M	$ 3.19M
Stockholders' Equity	$ ―	$ ―	$ ―	$ ―	$ ―
Cash Flow
Free Cash Flow	$ -15.73M	$ -15.47M	$ -1.20M	$ -623.00K	$ 781.00K
Operating Cash Flow	$ -11.19M	$ -8.36M	$ -1.20M	$ -623.00K	$ 781.00K
Investing Cash Flow
Financing Cash Flow

Nanalysis Scientific Earnings and Revenue History

Income Statement >

Nanalysis Scientific Debt to Assets

Balance Sheet >

Nanalysis Scientific Cash Flow

Cash Flow >

Nanalysis Scientific Forecast EPS vs Actual EPS

Earnings >